Dr. Lalchandani Labs Ltd

Dr. Lalchandani Labs Other Announcement

Dr Lalchandani Labs Ltd. received an extension from the Registrar of Companies to hold its AGM for FY 2025-26 by December 31, 2026.

Dr. Lalchandani Labs H2 FY26 Results: Net Loss of ₹0.1 Cr

Dr. Lalchandani Labs Ltd reported revenue from operations of ₹2.1 Cr (-8.7% YoY) and a net loss of ₹0.1 Cr for H2 FY26.

Key figure

Net loss ₹0.1 Cr

Dr. Lalchandani Labs Board Meeting Date

Dr Lalchandani Labs Limited postponed its May 30 board meeting to June 03, 2026. The delay allows for internal review of financial data before results approval.

Dr. Lalchandani Labs Capacity Expansion: ₹1 Cr Investment

Dr Lalchandani Labs opened a new strategic centre in Dwarka, Delhi. The facility targets a ₹1 Crore annual revenue contribution from local government employee residents.

Value

₹1.00 Cr

Dr. Lalchandani Labs Board Meeting Date

Dr Lalchandani Labs scheduled a board meeting on May 30, 2026, to approve annual audited financial results. The trading window remains closed until June 1.

Dr. Lalchandani Labs Other Announcement

Dr Lalchandani Labs Ltd confirmed it does not meet the 'Large Corporate' criteria for FY 2025-26 under SEBI debt-raising norms. The company reported zero incremental borrowings and no mandatory debt-sourcing requirements as its long-term borrowings remain below the Rs. 1000 crore threshold.

Dr. Lalchandani Labs Debt & Borrowing

Dr Lalchandani Labs Ltd confirmed it does not qualify as a Large Corporate entity for the financial year 2026. The company reported zero outstanding borrowings as of March 31, 2026, and is therefore not subject to SEBI's mandatory debt-raising framework for large entities.

Dr. Lalchandani Labs Management Change

Mrs. Saniya Hussain has resigned as Company Secretary and Compliance Officer of Dr Lalchandani Labs Limited, effective April 22, 2026. The resignation is due to personal and professional reasons. The company is in the process of fulfilling the necessary regulatory formalities regarding this change in senior management.

Dr. Lalchandani Labs Price Movement Clarification

Dr Lalchandani Labs Ltd clarified to the BSE that there is no pending price-sensitive information or announcement. The company stated that recent significant movements in its share price are entirely market-driven and not linked to any undisclosed corporate developments.